DDIT3 and metabolic dysfunction-associated steatotic liver disease: Salubrinal regulates lipid metabolism and down-regulates CHOP expression via the eIF2α signaling pathway to alleviate lipid accumulation in the liver, providing strategies to mitigate MASLD [40].